These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25263587)

  • 21. Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.
    Adam R; Delvart V; Karam V; Ducerf C; Navarro F; Letoublon C; Belghiti J; Pezet D; Castaing D; Le Treut YP; Gugenheim J; Bachellier P; Pirenne J; Muiesan P;
    Am J Transplant; 2015 Feb; 15(2):395-406. PubMed ID: 25612492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation.
    Potdar S; Malek S; Eghtesad B; Shapiro R; Basu A; Patel K; Broznick B; Fung J
    Clin Transplant; 2004 Dec; 18(6):661-5. PubMed ID: 15516240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference?
    Becker T; Ringe B; Nyibata M; Meyer zu Vilsendorf A; Schrem H; Lück R; Neipp M; Klempnauer J; Bektas H
    JOP; 2007 May; 8(3):304-11. PubMed ID: 17495359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function.
    Saitoh Y; Hashimoto M; Ku K; Kin S; Nosaka S; Masumura S; Nakayama K
    Ann Thorac Surg; 2000 Jan; 69(1):107-12. PubMed ID: 10654496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined St. Thomas and histidine-tryptophan-ketoglutarat solutions for myocardial preservation in heart transplantation patients.
    Lee KC; Chang CY; Chuang YC; Sue SH; Yang HS; Weng CF; Lee YT; Huang WS; Chen IC; Wei J
    Transplant Proc; 2012 May; 44(4):886-9. PubMed ID: 22564575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation.
    Lynch RJ; Kubus J; Chenault RH; Pelletier SJ; Campbell DA; Englesbe MJ
    Am J Transplant; 2008 Mar; 8(3):567-73. PubMed ID: 18162093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.
    Meine MH; Zanotelli ML; Neumann J; Kiss G; de Jesus Grezzana T; Leipnitz I; Schlindwein ES; Fleck A; Gleisner AL; de Mello Brandão A; Marroni CA; Cantisani GP
    Transplant Proc; 2006; 38(6):1872-5. PubMed ID: 16908310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation.
    Cavallari A; Cillo U; Nardo B; Filipponi F; Gringeri E; Montalti R; Vistoli F; D'amico F; Faenza A; Mosca F; Vitale A; D'amico D
    Liver Transpl; 2003 Aug; 9(8):814-21. PubMed ID: 12884193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation.
    Savier E; Brustia R; Golmard JL; Scatton O;
    J Visc Surg; 2020 Apr; 157(2):87-97. PubMed ID: 31548152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft Protection Against Cold Ischemia Preservation: An Institute George Lopez 1 and Histidine-tryptophan-ketoglutarate Solution Appraisal.
    Panisello-Rosello A; Castro-Benítez C; Lopez A; Balloji S; Folch-Puy E; Adam R; Roselló-Catafau J
    Transplant Proc; 2018 Apr; 50(3):714-718. PubMed ID: 29661422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial protection in donor heart preservation: a comparison between Bretschneider's histidine-tryptophan-ketoglutarate solution and cold blood cardioplegia.
    Sung SY; Lin CY; Song JY; Tsai YT; Kao CH; Lee CY; Lin YC; Hsu PS; Tsai CS
    Transplant Proc; 2014 May; 46(4):1077-81. PubMed ID: 24815133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation.
    Mangus RS; Tector AJ; Agarwal A; Vianna R; Murdock P; Fridell JA
    Liver Transpl; 2006 Feb; 12(2):226-30. PubMed ID: 16447203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts.
    Moench C; Otto G
    Int J Artif Organs; 2006 Mar; 29(3):329-34. PubMed ID: 16685677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of organ preservation solutions on short-term outcomes after liver transplantation: a single-center retrospective study.
    Van den Eynde J; Achtergaele J; Fieuws S; Jochmans I; Sainz-Barriga M; Monbaliu D; Pirenne J; Gilbo N
    Transpl Int; 2021 Feb; 34(2):327-338. PubMed ID: 33280170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of apoptosis in the liver preserved by simple hypothermia using histidine-tryptophan-ketoglutarate and prolactin-modified histidine-tryptophan-ketoglutarate solution.
    Budziński G; Wiaderkiewicz R; Caban A; Suszka-Świtek A; Oczkowicz G; Wystrychowski W; Heitzman M; Dolińska B; Ryszka F; Cierpka L
    Transplant Proc; 2011 Oct; 43(8):2900-2. PubMed ID: 21996184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenaline and dopamine in porcine livers after cold preservation with University of Wisconsin histidine-tryptophan-ketoglutarate, prolactin-modified histidine-tryptophan-ketoglutarate solutions.
    Budziński G; Suszka-Świtek A; Dec R; Caban A; Wystrychowski W; Oczkowicz G; Heitzman M; Dolińska B; Ryszka F; Cierpka L
    Transplant Proc; 2011 Oct; 43(8):2895-6. PubMed ID: 21996182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas).
    Kniepeiss D; Houben P; Stiegler P; Berghold A; Riedl R; Kahn J; Schemmer P
    Trials; 2020 Jan; 21(1):62. PubMed ID: 31924234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens.
    George TJ; Arnaoutakis GJ; Beaty CA; Shah AS; Conte JV; Halushka MK
    J Heart Lung Transplant; 2012 Apr; 31(4):410-8. PubMed ID: 22209353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on abdominal organ preservation solutions: a comparative literature review.
    Voigt MR; DeLario GT
    Prog Transplant; 2013 Dec; 23(4):383-91. PubMed ID: 24311404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.